PAA 10.3% 37.5¢ pharmaust limited

MPL Clinical Trials in Dogs Diagnosed with Cancer - RESULTS from B-cell lymphoma trials.

  1. 473 Posts.
    lightbulb Created with Sketch. 748

    Hi All,
    Has everyone seen and read the following?
    Is this not what the market wants to read in the upcoming K9 trials?
    IMO, the second paragraph two says it all...and IMO, is a prelude the the imminent announcement.

    MPL Clinical Trials in Dogs Diagnosed with Cancer

    In a Phase I trial conducted in dogs diagnosed with solid tumours, MPL was shown to be well tolerated and reported as beneficial to Quality of Life (QOL) in canines with cancer doses up to 25 mg/kg bw daily either as monotherapy or at 5 mg/kg bw in combination with carboplatin. Further, MPL dosed at 5 mg/kg bw daily in canines with “standard of care” treatment-refractory cancer effectively and significantly reduces blood levels of the cancer-specific marker p-Rbps6k.



    In a Phase 2 pilot programme, dogs diagnosed with lymphoma were treated with MPL as front-line therapy with doses up to 25mg/kg/day for two weeks before transitioning to standard therapy. Results showed that 100% of dogs diagnosed with B-cell lymphoma developed stable disease and showed evidence of tumour regression with minimal side-effects following MPL treatment. Lymphoma in dogs is very aggressive and, without treatment, the tumours are often fatal within weeks.
    (Taken from PharmAust's website under pipelines and trials.)

    Looking forward to the canine results........

    AS Always
    Best
    Mickey Mouse

 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
37.5¢
Change
0.035(10.3%)
Mkt cap ! $146.4M
Open High Low Value Volume
34.5¢ 38.0¢ 34.5¢ $542.7K 1.474M

Buyers (Bids)

No. Vol. Price($)
1 14511 37.0¢
 

Sellers (Offers)

Price($) Vol. No.
37.5¢ 18443 1
View Market Depth
Last trade - 16.10pm 28/03/2024 (20 minute delay) ?
Last
37.0¢
  Change
0.035 ( 8.82 %)
Open High Low Volume
34.5¢ 38.0¢ 34.5¢ 757697
Last updated 15.59pm 28/03/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.